← Evidence map

ArticleFrontiers in oncology2023

Multimodality MRI radiomics analysis of TP53 mutations in triple negative breast cancer.

Kun Sun et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

6 papers cite it

2023
2024
2025
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 37064157